Daniel Young, PhD
Posts by Daniel Young, PhD
On its face, the new guidance seems to urge examiners to develop well-reasoned, substantive rejections rather than conclusory rejections which provide little basis for applicants to advance …
Daniel Young, PhD is an attorney with Wolf Greenfield. Dr. Young works with clients across a broad range of technology areas to develop and implement IP strategies that are aligned with their business goals through portfolio management, patent prosecution, due diligence support, and third-party IP evaluations, focusing primarily in the areas of cell-based therapies, nucleic acid-based therapies, immuno-oncology approaches, antibodies, vaccines, gene therapies, genomics and bioinformatics, biomedical devices, marine and clean energy technologies. For more information, or to contact Dr. Young, please visit his firm profile page.